Wednesday, November 11, 2026
Home Authors Posts by Ogkologos

Ogkologos

4396 POSTS 0 COMMENTS

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-mutated, HR-positive,...

Ogkologos -
0

EMA Recommends Extension of Indications for Tislelizumab to First-Line Treatment of...

Ogkologos -
0

Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible...

Ogkologos -
0

How Do Black People with Cancer View Clinical Research?

Ogkologos -
0

Adding Cadonilimab to First-Line Standard Chemotherapy Significantly Improves PFS and OS...

Ogkologos -
0

Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma

Ogkologos -
0

iDFS Benefit with Ribociclib Plus Nonsteroidal Aromatase Inhibitor in Patients with...

Ogkologos -
0

FDA Approves Zolbetuximab-clzb with Chemotherapy for Gastric or Gastro-Oesophageal Junction Adenocarcinoma

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Catumaxomab

Ogkologos -
0

Greater OS Benefit Among Patients with Advanced Cancer Treated with Matched...

Ogkologos -
0
1...646566...440Page 65 of 440

MOST POPULAR

Load more

HOT NEWS

Information on cancer, treatments, support and developments in oncology.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2026 Ogkologos.com